Electrical Nerve Block for Phantom Limb Pain
Trial Summary
What is the purpose of this trial?
The purpose of the clinical trial is to learn whether electrical nerve block via the Altius System is a safe and effective treatment for patients with post-amputation pain.
Will I have to stop taking my current medications?
No, you will not have to stop taking your current medications. The trial requires that you maintain a stable drug regimen for at least 4 weeks before starting and make no changes to your medications during the 3-month primary study period.
What data supports the effectiveness of the Altius System treatment for phantom limb pain?
Research shows that electrical stimulation, similar to the Altius System, has provided excellent or partial relief of phantom limb pain in patients. Additionally, peripheral nerve stimulation, which is a component of the Altius System, has been shown to significantly reduce phantom limb pain in some patients.12345
Is the Electrical Nerve Block treatment safe for humans?
How does the Altius System treatment for phantom limb pain differ from other treatments?
The Altius System is unique because it uses a high-frequency nerve block (HFNB) delivered through a cuff electrode on the peripheral nerve and an implantable pulse generator, offering a novel approach compared to traditional methods like short-term nerve blocks or electrical stimulation, which may not provide long-term relief.124910
Research Team
Leonardo Kapural, MD
Principal Investigator
Center for Clinical Research, Winston-Salem NC
Eligibility Criteria
This trial is for adults over 21 with chronic pain after leg amputation, lasting at least 6 months. Candidates must have had their limb amputated for over a year and be on a stable medication regimen without changes to medications or prosthesis planned during the study. Exclusions include those needing MRI post-implant, with active medical devices like pacemakers, untreated major psychological issues, life expectancy under two years, other major pain sources or conditions like uncontrolled diabetes.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Implantation and Initial Testing
Implantation of the Altius System and initial testing of the device
Randomized Testing Window
Participants receive either the high frequency bioelectric nerve block or a sham control treatment
Follow-up
Participants are monitored for safety and effectiveness, including pain reduction and quality of life assessments
Treatment Details
Interventions
- Altius System
Find a Clinic Near You
Who Is Running the Clinical Trial?
Neuros Medical, Inc.
Lead Sponsor